Total Ancillary - FloodGate Medical

Smarter Wound Care Management

About Us

Total Ancillary is your premier partner in end-to-end advanced wound care solutions. Our team is forward-thinking, ever evolving and committed to delivering innovative products, services and technologies that prioritize patient well-being and provider satisfaction.

With years of experience in the healthcare sector, our team understands the unique challenges faced by healthcare providers and their practices, which is what led to the company’s founding. By combining the team’s passion and knowledge with cutting-edge technologies, Total Ancillary has created a comprehensive suite of products and services, tailored to meet all your wound care needs.

Look at the Leaders of Total Ancillary

Phil Webb

Chief Financial Officer

Joe Smithco

Chief Sales Officer

Greg Yager

Chief Commercial Officer

Featured Services and Innovations

Healthview 360

An end-to-end skin substitute management platform that combines benefits verification, supply chain management, and robust data analytics to help you deliver best-in-class wound care services and therapies.

Esano™ AC

Esano™ AC Dual Layer Amnion-Chorion Membrane Allograft is a dehydrated human amniotic membrane allograft derived from placental tissue. It can be used as a wound covering for acute or chronic wounds, serving as a protective barrier.

The product aids in granulation tissue development in acute and chronic wounds. It is easy to apply, can be used with or without glue or sutures, and has a high tensile strength for suturing or stapling if required. The allograft also has a five-year shelf life and can be stored at room temperature.

Axolotl™

Axolotl DualGraft™ is dehydrated human amnion membrane allograft derived from the amniotic lining of the placenta. Axolotl DualGraft™ is indicated as a wound covering and structural barrier.

Axolotl™ graft product is processed through minimal manipulation techniques, retaining the native qualities of the amniotic membrane to function as a wound covering and as a structural barrier.

Axolotl DualGraft™ is marketed under Section 361 of the PHS act and regulated under 21 CFR Part 1271.

Axolotl™ graft product have received a letter of recommendation from the FDA Tissue Reference Group (TRG) and are manufactured in an AATB accredited manufacturing environment.

RevoShield+®

RevoShield+® Dual Layer Amnion Patch is a dehydrated human amniotic membrane allograft derived from the submucosa of placental tissue. This patch may be used as a wound covering for acute or chronic wounds, serving as a protective barrier.

RevoShield+® aids in tissue reconstruction and wound management by serving as a protective barrier that limits moisture loss. It is easy to apply with or without glue or sutures, stores at room temperature, and offers a five-year shelf life for convenient, long-term use.

AMNIO-MAXX®

Amnio-Maxx® is a dual layered, dehydrated, amniotic tissue membrane graft derived from placental tissue. This product is used for chronic, non-healing wounds such as diabetic foot ulcers and venous leg ulcers or soft tissue defects.

Amnio-Maxx® features a dual-layer structure that offers twice the growth factor content to support tissue regeneration. The thicker graft design enhances handling during robotic and laparoscopic procedures. Its chorion-free, immune-privileged profile minimizes the risk of adverse reactions, while the dual-sided configuration allows for easy placement without orientation restrictions.

Additionally, Amnio-Maxx® provides exceptional biomechanical integrity – offering greater tensile strength, improved shape manipulation, and slower resorption in vivo1 – making it an ideal choice for demanding surgical environments.

Company Spotlight Video

News and Stories

Total Ancillary Joins Forces with WoundGenex

DALLAS, May 22, 2025 (GLOBE NEWSWIRE) — Providers now will have access to additional support services, thanks to an alliance between leading wound care solutions provider Total Ancillary and WoundGenex, a trusted name in wound care associated administrative services. The partnership enhances Total Ancillary’s ability to deliver an end-to-end ecosystem of support from patient scheduling to treatment, coding, billing and reimbursement.

Total Ancillary Launches Healthview360™

DALLAS, Jan. 16, 2025 (GLOBE NEWSWIRE) — Wound care management innovator Total Ancillary announces the full market launch of Healthview360™, an advanced SaaS (software-as-a-service) enablement platform designed to transform operations for wound care providers, clinic administration, staff and their representatives.

Looking to stand out from the crowd during your job search? Click below to gain access to our top tips & tools for candidates during the hiring process!

Recruiting Done Differently.

Improving lives by uniting great people with great companies.

Sign up for our Monthly Newsletter

We’re committed to sharing up-to-date industry insights, our newest career opportunities, and valuable tools to support you throughout your next job search. Let’s stay connected!